ClinVar Miner

Submissions for variant NM_000051.4(ATM):c.1773T>C (p.Asn591=)

gnomAD frequency: 0.00013  dbSNP: rs61734356
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 19
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000211968 SCV000167066 benign not specified 2014-04-29 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000123723 SCV000213137 likely benign Hereditary cancer-predisposing syndrome 2014-09-12 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV001085839 SCV000252943 likely benign Ataxia-telangiectasia syndrome 2024-02-01 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000123723 SCV000537441 likely benign Hereditary cancer-predisposing syndrome 2015-08-04 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000211968 SCV000694198 likely benign not specified 2019-08-20 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000196069 SCV001148404 likely benign not provided 2022-08-01 criteria provided, single submitter clinical testing ATM: BP7
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000196069 SCV001469346 likely benign not provided 2021-09-03 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000196069 SCV001474785 likely benign not provided 2019-10-15 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001798412 SCV002043429 likely benign Breast and/or ovarian cancer 2022-10-03 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000196069 SCV002048163 likely benign not provided 2023-08-24 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000123723 SCV002533353 likely benign Hereditary cancer-predisposing syndrome 2021-03-16 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000211968 SCV004027159 likely benign not specified 2023-08-15 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000196069 SCV004226228 uncertain significance not provided 2022-07-15 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV004589614 SCV005083851 benign Familial cancer of breast 2024-05-01 criteria provided, single submitter clinical testing This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
Breakthrough Genomics, Breakthrough Genomics RCV000196069 SCV005215747 likely benign not provided criteria provided, single submitter not provided
Natera, Inc. RCV001085839 SCV001461083 likely benign Ataxia-telangiectasia syndrome 2020-04-16 no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000196069 SCV001808917 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute RCV000196069 SCV001906019 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000196069 SCV002037359 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.